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Özet
Amaç: Hepatit A virüsü, (HAV) ribonükleik asit (RNA) içeren picornavirüs olup 
fekal-oral yolla bulşmaktadır. HAV genellikle sessiz veya subklinik seyretmek-
te olup hastalığın sadece %5’i klinik olarak tanımlanabilmektedir. Bu çalışma-
da Türkiye’de Ege bölgesinde bulunan iki farklı hastenede HAV seropozitifliği-
nin belirlenmesi amaçlandı. Gereç ve Yöntem: Uşak Devlet Hastanesi ve Tav-
şanlı Devlet Hastanesi’ne başvuran ve Ocak 2011 ile Aralık 2011 dönemin-
de serum alınarak hepatit A antikorları araştırılan hastalarda hepatitit A se-
ropozitifliği retrospektif olarak irdelendi. Yaş, cinsiyet, Anti HAV Ig G and Anti 
HAV Ig M de araştırıldı. Bulgular: Uşak Devlet Hastanesinden 799, Tavsşanlı 
Devlet Hastanesi’nden 461 hasta Anti HAV Ig G ve Anti HAV Ig M seropozitif-
liği açısından incelendi. Uşak Devlet Hastanesi’nde hastaların % 78’i kadın, % 
22’si erkek, yaş ortalaması 27,7 idi. Tavşanlı Devlet Hastanesi’nde hastaların 
% 54’ü kadın, % 46’sı erkek ve yaş ortalaması 38 idi.  Uşak ve Tavşanlı Dev-
let Hastanelerinde Anti-HAV Ig M pozitifliği sırasıyla % 1,3 ve % 0,6 olarak 
bulundu. Anti-HAV Ig G pozitifliği ise Uşak ve Tavşanlı’da sırasıyla % 75,5 ve 
% 80,4 olarak bulundu. Sonuç: Toplum ve bireylerin hijyen düzeyinin geliştiril-
mesi, hijyen konusunda eğitim verilmesi, eğitim ve sosyoekeonomik seviyenin 
geliştirilmesi, Dünya Sağlık Örgütü önerileri doğrultusunda hepatit A aşısı-
nın uygulanması hepatit A enfeksiyonu sıklığının azalmasına yol açabilecektir. 
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Abstract
Aim:  Hepatitis  A  virus  (HAV)  is  a  ribonucleic  acid  (RNA)  picornavirus 
transmitted by fecal-oral route. HAV is usually silent or subclinic in children 
and on a worldwide scale only 5 % of infections are recognised clinically. In 
this study we aimed to determine the seroprevalance of HAV seropositivity in 
two different hospitals in the Aegean region of Turkey. Material and Method: 
Serum samples, which were taken from patients to investigate hepatitis A 
antibodies  administrated to Usak State Hospital and Tavsanli Doc. Dr. M. 
Kalemli State Hospital between January 2011 and December 2011 were 
investigated for hepatitis A seropositivity retrospectively. Age, sex, Anti HAV 
Ig G and Anti HAV Ig M were investigated. Results: 799 patients in Usak State 
Hospital and 461 patients in Tavsanli State hospital   were investigated for 
Anti HAV Ig G and Anti HAV Ig M. 78 % were female, 22 % were male and 
mean age was 27,7 in Usak State Hospital. 54 % were female, 46 % were 
male, mean age was 38,0 in Tavsanli State Hospital. Anti-HAV Ig M positivity 
in Usak and Tavsanli State Hospital are 1,3 % and 0,6 % respectively. Anti-
HAV Ig G positivity in Usak and Tavsanli State Hospital are 75,5 % and 80,4 
% respectively. Discussion: Improvement of public and individual hygiene, 
education about hygiene, improvement of education and socioeconomic level 
of public and vaccination against HAV as recommended by the World Health 
Organisation may decrease the burden of HAV infection.
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Introduction
Hepatitis A virus (HAV) is a ribonucleic acid (RNA) picornavirus 
transmitted by fecal-oral route, either from contaminated food 
or water or from person to person. The clinical manifestations 
vary with the age and it’s severity and fatality increase with 
the age [1]. HAV is usually silent or subclinic in children and on 
a worldwide scale only 5 % of infections are recognised clini-
cally [2]. Asymptomatic infection is more common in children 
under 6 years [3]. The mean incubation period is 30 days rang-
ing from 2 to 6 weeks. The infection usually results in an acute 
self limited illnes and rarely leads to fulminant hepatic failure. 
Approximately 85 % of infected patients have full recovery in 3 
months and have complete recovery by 6 months[4].
HAV is endemic in Southeast Asia and many parts of the world. 
The epidemiologic patterns vary, although the differences are 
linked  more  to  socioeceonomic  conditions  than  actual  geo-
graphic regions. In  countries where a lack of adequate sanita-
tion and poor hygiene practices, facilitate the spread of infec-
tion, subclinical infection is common and most of the children 
get immune by the age of 10 years. In developed countries with 
high standards of hygiene or sanitation, infection is uncommon 
in the young and the infection is usually acquired in travels to 
endemic areas [5,6]. The age spesific prevalance of antibodies 
to HAV in developed countries therefore tends to be a sigmoid 
curve, with a low prevalance among children and a high preva-
lance among the elderly [7].
Determination of anti-HAV antibodies in a population provides 
more reliable estimates of HAV infection prevalance [8]. In this 
study we aimed to determine the seroprevalance of HAV se-
ropositivity in two different hospitals in the Aegean region of 
Turkey. 
Material and Method
Serum samples, which were taken from patients to investigate 
hepatitis A antibodies  administrated to Usak State Hospital 
and Tavsanli Doc. Dr. M. Kalemli State hospital between Janu-
ary 2011 and December 2011 were investigated for hepatitis A 
seropositivity retrospectively. Age, sex, Anti HAV Ig G and Anti 
HAV Ig M were investigated. The patients were classified among 
their ages (0-5, 6-10, 11-20, 21-30, 31-40, 41-50, 51-60 and 
over 61 years of age). Anti HAV Ig G and Anti HAV Ig M were 
investigated by Architect i2000 sr (Abbott, USA) in Usak State 
Hospital and by Axsym (Abbott, USA) in Tavsanli State Hospital 
by the chemiluminescence microparticle immunoassay (CMIA).
Statistical analysis was made by using SPSS v17 for Windows.
Results
799 patients in Usak State Hospital and 461 patients in Tavsan-
li State hospital   were investigated for HAV Ig G and HAV Ig 
M. 625 of the patients ( 78 %) were female, 174 (22 %) were 
male, mean age was 27,7 ( between 5 months and 86 years of 
age) in Usak State Hospital. 247 of the patients ( 54 %) were 
female, 214 (46 %) were male, mean age was 38,0 ( between 
1 month and 95 years of age) in Tavsanli State Hospital. Anti-
HAV Ig M positivity in Usak and Tavsanli State Hospital are 1,3 
% and 0,6 % respectively. Anti-HAV Ig G positivity in Usak and 
Tavsanli State Hospital are 75,5 % and 80,4 % respectively. Se-
ropositivity among the groups are shown in Table 1. There was 
significant difference between age groups in both of the hospi-
tals; Anti HAV Ig G seropositivity in 0-10 years of age group was 
significantly lower than that of the group older than 10 years 
group (p<0,05). There was no statistically significance between 
the age groups of Tavsanli and Usak State Hospitals.
Discussion
To our knowledge this is the first study that investigated the se-
ropositivity of HAV in Usak and Tavsanli. Among the age groups, 
seropositivity is low in the first 10 years (19,6 % in Usak and 
19,2 % in Tavsanli). Seropositivity increases up to % 100 over 
61 years in Usak and 93,7 % in Tavsanli. 
Kanra et al. [9] reported that HAV seroprevalance was 71,3 % 
in the sera of 4462 subjects under th age of 30 in Turkey. They 
also  reported  that  HAV  seroprevalance  in  children  under  10 
years as 50 %.  
Akbulut et al. [10] reported that the seroprevalance of HAV was 
72,5 % in 0-18 years group of children. Colak et al. [11] reported 
the seropositivity of HAV as 19,9 % in 0-5 years group and 43,9 
% in 6-12 years children. Sencan et al. [12] reported the sero-
positivity in 0-6 years children as 44,4 %. 
Okur et al. [13] reported that the HAV seropositivity as 69,9 % in 
children between 0-18 years. They reported that the seroposi-
tivity was lower in 0-2 years group (53,1 %). They also reported 
that the seropositivity was increasing with the age and rising up 
to 92,3% in 16-18 years group.
Kurugol et al. [8] reported that the seropositivity under the age 
of 30 is 23,9 % in Cyprus. They also reported that the indicators 
of lower socioeconomic status like low family income, crowding, 
absence of waste water sewage and lower education of parents 
were significantly associated with higher anti-HAV prevalance. 
Seropositivity of HAV may vary according to the geographic re-
gion and the socieconomic status of the countries. Lee et al. 
[7] reported that the HAV seropositivity was 25,9 % in Singa-
pore. Strict control of food import by the authorities and pub-
lic health education on the risk of consuming shellfish and raw 
and half-cooked food decreased the seropositivity of HAV IgM 
from 1,8 % in 1989 to 0,7 % in 2001. Lee et al. [14] reported 
that the seropositivity of HAV Ig G was 53,8 % in Korea. They 
showed that the prevalance was increasing with the age, but 
the subjects aged 20-29 was showing the least amount of se-
ropositivity. The change in seropositivity was associated with 
the development of Korea accompanied by an improvement in 
Age group n Anti HAV IgG 
positivity in Usak 
n (%)
n Anti HAV IgG 
positivity in 
Tavsanli n (%)
0-5 years 53 9 (16.9) 12 3 (25)
6-10 years 44 10 (22.7) 14 2 (14.2)
11-20 years  116 65 (56.0) 54 26 (8.1)
21-30 years  334 278 (83.2) 89 69 (77.5)
31-40 years 142 137 ( 96.4) 90 82 (91.1)
41-50 years 39 36 (93.3) 81 77 (90.5)
51-60 years 38 36 (94.7) 73 67 (91.7)
>61 years 33 33 (100) 48 45 (93.7)
Total 799 604 (75.5) 461 371(80.4)
Table 1. Anti HAV Ig G seropositivity among age groups (n: number of patients)
Journal of Clinical and Analytical Medicine  | 105
Hepatitit A Seropozitifliği/ Hepatitis A SeropositivityJournal of Clinical and Analytical Medicine  | 
Hepatitit A Seropozitifliği/ Hepatitis A Seropositivity
3
individual and social hygiene [14,15]. Pham et al. [16] showed 
that the seropositivity of HAV in Canada was 1% in 8-13 ages 
group and increasing up to 17 % in 30-39 years group. These 
results are lower than those obtained from our country and also 
from those obained from Cyprus, Singapore and Korea. These 
results show that HAV seropositivity is related with socioeco-
nomic factors which have influence on hygiene. Homosexuality, 
travel to endemic area were found related with the seropositiv-
ity. The major risk for low endemic countries is an outbreak of 
the infection[16,17].  
This study shows higher seropositivity than more developed for-
eign countries, similar to other studies from Turkey. The results 
of Anti HAV Ig  G in the 0-10 and 11-20 years groups are lower 
than other studies from Turkey [9-13]. This may be due to the 
fact that Aegean region is more developed and personal hygiene 
is better than the other parts of Turkey. Public and personal hy-
giene has remarkably improved in the last decade in Turkey by 
the socioeconomic development.  There is a minor decrease in 
the 41-50 years group which is not statistically significant.
Anti HAV Ig G seropositivity in Tavsanli is higher than Usak. This 
may be due to the mean age, which is greater in Tavsanli and 
also due to the socioeconomic development of a province than 
a town.
Improvement of public and individual hygiene, education about 
hygiene,  improvement  of  education  and  socioeconomic  level 
of public and vaccination against HAV as recommended by the 
World Health Organisation may decrease the burden of HAV in-
fection.
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